Carisbamate add‐on therapy for drug‐resistant focal epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Carisbamate Add‐on Therapy for Drug‐resistant Focal Epilepsy." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432117/all/images/google-play-badge.png. Accessed 02 May 2024.
Carisbamate add‐on therapy for drug‐resistant focal epilepsy. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432117/all/images/google-play-badge.png. Accessed May 2, 2024.
Carisbamate add‐on therapy for drug‐resistant focal epilepsy. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432117/all/images/google-play-badge.png
Carisbamate Add‐on Therapy for Drug‐resistant Focal Epilepsy [Internet]. In: Cochrane Abstracts. [cited 2024 May 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432117/all/images/google-play-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Carisbamate add‐on therapy for drug‐resistant focal epilepsy
ID - 432117
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432117/all/images/google-play-badge.png
DB - Evidence Central
DP - Unbound Medicine
ER -